Breakingviews: Drugmakers' D.C. dealing

As Congress prods Mylan over EpiPen in the latest probe on prescription prices, the pharmaceutical industry's massive lobbying spend gets put to the test. Gina Chon and Jeffrey Goldfarb discuss.

Read more